|
Volumn 47, Issue 9, 2008, Pages 1122-1127
|
Active immunotherapy of urologic malignancies and tumor-mediated immunosuppression;Aktive immuntherapie urologischer tumoren und tumorbedingte immunsuppression
|
Author keywords
Immunotherapy; Myeloid derived suppressor cells; Regulatory T cells; Vaccine
|
Indexed keywords
GAMMA INTERFERON;
INTERLEUKIN 2;
PROSTATE SPECIFIC ANTIGEN;
TUMOR CELL VACCINE;
VASCULOTROPIN;
BONE MARROW CELL;
CANCER IMMUNOTHERAPY;
DRUG SAFETY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
PROPHYLAXIS;
PROSTATE CANCER;
REGULATORY T LYMPHOCYTE;
REVIEW;
URINARY TRACT CANCER;
ADMINISTRATION, INTRAVESICAL;
ANTIBODY FORMATION;
BCG VACCINE;
CANCER VACCINES;
CARCINOMA, RENAL CELL;
CARCINOMA, TRANSITIONAL CELL;
CD8-POSITIVE T-LYMPHOCYTES;
HUMANS;
IMMUNE TOLERANCE;
IMMUNOTHERAPY, ACTIVE;
INTERFERON-GAMMA;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
MALE;
PROSTATIC NEOPLASMS;
T-LYMPHOCYTES, REGULATORY;
URINARY BLADDER NEOPLASMS;
|
EID: 51349104774
PISSN: 03402592
EISSN: None
Source Type: Journal
DOI: 10.1007/s00120-008-1822-2 Document Type: Review |
Times cited : (1)
|
References (39)
|